These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33411194)

  • 1. Intrinsic motivation in patients with Parkinson's disease: a neuropsychological investigation of curiosity using dopamine transporter imaging.
    Shigemune Y; Kawasaki I; Midorikawa A; Baba T; Takeda A; Abe N
    Neurol Sci; 2021 Aug; 42(8):3349-3356. PubMed ID: 33411194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased sensitivity to loss of options in patients with Parkinson's disease.
    Shigemune Y; Kawasaki I; Baba T; Takeda A; Abe N
    Neuropsychologia; 2022 Sep; 174():108322. PubMed ID: 35839962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K; Wegner F; Hesse S; Becker GA; Patt M; Meyer PM; Lobsien D; Schwarz J; Sabri O
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
    Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
    Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients.
    Hirata K; Hattori T; Kina S; Chen Q; Ohara M; Yokota T
    Mov Disord; 2020 Jun; 35(6):1037-1045. PubMed ID: 32163636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide variant by serum urate interaction in Parkinson's disease.
    Nazeri A; Roostaei T; Sadaghiani S; Chakravarty MM; Eberly S; Lang AE; Voineskos AN
    Ann Neurol; 2015 Nov; 78(5):731-41. PubMed ID: 26284320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal dopamine transporter availability in early Parkinson's disease.
    Fazio P; Svenningsson P; Cselényi Z; Halldin C; Farde L; Varrone A
    Mov Disord; 2018 Apr; 33(4):592-599. PubMed ID: 29436751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
    Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
    J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
    Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine transporter availability in Parkinson's disease patients with or without depression.
    Hesse S; Meyer PM; Strecker K; Barthel H; Wegner F; Oehlwein C; Isaias IU; Schwarz J; Sabri O
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):428-35. PubMed ID: 19037640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT.
    Yokoyama K; Imabayashi E; Sumida K; Sone D; Kimura Y; Sato N; Mukai Y; Murata M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):366-372. PubMed ID: 27544223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease.
    Sawamoto N; Piccini P; Hotton G; Pavese N; Thielemans K; Brooks DJ
    Brain; 2008 May; 131(Pt 5):1294-302. PubMed ID: 18362097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced motivation of cognitive control in Parkinson's disease.
    Timmer MHM; Aarts E; Esselink RAJ; Cools R
    Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease.
    Jaakkola E; Joutsa J; Mäkinen E; Johansson J; Kaasinen V
    Eur J Neurol; 2017 Nov; 24(11):1341-1347. PubMed ID: 28834102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation and dopamine terminal loss in early Parkinson's disease.
    Ouchi Y; Yoshikawa E; Sekine Y; Futatsubashi M; Kanno T; Ogusu T; Torizuka T
    Ann Neurol; 2005 Feb; 57(2):168-75. PubMed ID: 15668962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.